A New Personalized, Patient-Centric, and Cost-Conscious Guideline for Contemporary Cholesterol Management

JAMA. 2019 Feb 26;321(8):749-750. doi: 10.1001/jama.2019.0045.
No abstract available

Publication types

  • Comment

MeSH terms

  • Advisory Committees
  • American Heart Association*
  • Cardiology*
  • Cholesterol
  • Humans
  • Proliferating Cell Nuclear Antigen
  • United States

Substances

  • Proliferating Cell Nuclear Antigen
  • Cholesterol